NCT04479475Completed
Social Networks and Methadone Maintenance Treatment Retention and Antiretroviral Therapy Retention in Tanzania
Understanding the Role of Social Networks in Methadone Maintenance Treatment Retention and Antiretroviral Therapy Adherence Among People Who Inject Drugs in Tanzania
Source: ClinicalTrials.gov · Last updated 8 Oct 2025
Brief summary (registry, in English)
Investigators will adapt the Brief Social Behaviour and Network Therapy (B-SBNT) intervention developed to facilitate recovery among people receiving medication-assisted treatment for opioid use disorder in the United Kingdom. The B-SBNT involves families and the wider social networks of people receiving medications for opioid use disorder to support recovery. Key components of the intervention include: mapping the social networks of clients; inviting others identified through the mapping to participate in the intervention; building communication strategies with network members; and developing joint activities with network members. In the original B-SBNT, the intervention is delivered by therapists/clinicians who undergo training. Investigators will pilot test the adapted version of this intervention with a maximum of 80 people: 20 current clients receiving methadone maintenance treatment (MMT) at the Muhimbili National Hospital (MNH) Medically-Assisted Treatment (MAT) Clinic and up to 60 social support persons identified by recruited MMT clients. The pilot will assess the social network intervention's acceptability and feasibility.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 13 Jul 2020
- Start date
- 1 Mar 2024
- Primary completion date
- 5 Sept 2024
- Lead sponsor
- Johns Hopkins Bloomberg School of Public Health
- Diseases
- HIV
- NCT number
- NCT04479475
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 1 Mar 2024 to the primary completion date, 5 Sept 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Does not meet inclusion criteria
Who the study is looking for
- 18 years old or older,
- currently enrolled in the MAT program at the Muhimbili MAT clinic,
- prescribed methadone for the past 3 months,
- received a positive test result for heroin, cannabis or alcohol use in the past 3 months,
- provide consent for trial participation.
- 18 years old or older,
- identified as a social support person of a MMT client participating in the pilot trial
- lives in Dar es Salaam,
- provide consent for trial participation.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Muhimbili National Hospital Coordinator of this site? Confirm its status | Dar es Salaam | Tanzania | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.